160 related articles for article (PubMed ID: 24932975)
1. Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice.
Lee EJ; Kim JL; Kim YH; Kang MK; Gong JH; Kang YH
Phytomedicine; 2014 Sep; 21(10):1208-15. PubMed ID: 24932975
[TBL] [Abstract][Full Text] [Related]
2. Anti-perimenopausal osteoporosis effects of Erzhi formula via regulation of bone resorption through osteoclast differentiation: A network pharmacology-integrated experimental study.
Qin XY; Niu ZC; Han XL; Yang Y; Wei Q; Gao XX; An R; Han LF; Yang WZ; Chai LJ; Liu EW; Gao XM; Mao HP
J Ethnopharmacol; 2021 Apr; 270():113815. PubMed ID: 33444724
[TBL] [Abstract][Full Text] [Related]
3. A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice.
Kalyanaraman H; Ramdani G; Joshua J; Schall N; Boss GR; Cory E; Sah RL; Casteel DE; Pilz RB
J Bone Miner Res; 2017 Jan; 32(1):46-59. PubMed ID: 27391172
[TBL] [Abstract][Full Text] [Related]
4. Catalpol attenuates osteoporosis in ovariectomized rats through promoting osteoclast apoptosis via the Sirt6-ERα-FasL axis.
Chen S; Jin J; Xu Z; Han H; Wu L; Li Z
Phytomedicine; 2024 Jan; 123():155262. PubMed ID: 38100921
[TBL] [Abstract][Full Text] [Related]
5. Piperlongumine, a
Luo N; Zhang L; Xiu C; Luo X; Hu S; Ji K; Liu Q; Chen J
Food Funct; 2024 Feb; 15(4):2154-2169. PubMed ID: 38311970
[TBL] [Abstract][Full Text] [Related]
6. Cirsium Setidens Water Extracts Containing Linarin Block Estrogen Deprivation-Induced Bone Loss in Mice.
Oh MS; Kim SI; Sim YE; Park SH; Kang MK; Kang IJ; Lim SS; Kang YH
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675135
[TBL] [Abstract][Full Text] [Related]
7. Protaetia brevitarsis seulensis larvae ethanol extract inhibits RANKL-stimulated osteoclastogenesis and ameliorates bone loss in ovariectomized mice.
Choi RY; Kim IW; Ji M; Paik MJ; Ban EJ; Lee JH; Hwang JS; Kweon H; Seo M
Biomed Pharmacother; 2023 Sep; 165():115112. PubMed ID: 37413903
[TBL] [Abstract][Full Text] [Related]
8. Zoledronic acid modulates osteoclast apoptosis through activation of the NF-κB signaling pathway in ovariectomized rats.
Cheng YT; Liao J; Zhou Q; Huo H; Zellmer L; Tang ZL; Ma H; Hong W; Liao DJ
Exp Biol Med (Maywood); 2021 Aug; 246(15):1727-1739. PubMed ID: 33926259
[TBL] [Abstract][Full Text] [Related]
9. The novel small molecule E0924G dually regulates bone formation and bone resorption through activating the PPARδ signaling pathway to prevent bone loss in ovariectomized rats and senile mice.
Li Y; Liu C; Han X; Sheng R; Bao L; Lei L; Wu Y; Li Q; Zhang Y; Zhang J; Wang W; Zhang Y; Li S; Wang C; Wei X; Wang J; Peng Z; Xu Y; Si S
Bioorg Chem; 2024 Jun; 147():107364. PubMed ID: 38636434
[TBL] [Abstract][Full Text] [Related]
10. p300/CBP inhibitor A-485 inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss.
Huo S; Liu X; Zhang S; Lyu Z; Zhang J; Wang Y; Nie B; Yue B
Int Immunopharmacol; 2021 May; 94():107458. PubMed ID: 33626422
[TBL] [Abstract][Full Text] [Related]
11. Muramyl dipeptide alleviates estrogen deficiency-induced osteoporosis through canonical Wnt signaling.
Park OJ; Kwon Y; Kim J; Park C; Yun CH; Han SH
J Pathol; 2023 Jun; 260(2):137-147. PubMed ID: 36811349
[TBL] [Abstract][Full Text] [Related]
12. Effect of Menaquinone-4 on Receptor Activator of Nuclear Factor
Lee AS; Sung MJ; Son SJ; Han AR; Hong SM; Lee SH
J Med Food; 2023 Feb; 26(2):128-134. PubMed ID: 36724309
[TBL] [Abstract][Full Text] [Related]
13. Fas receptor is required for estrogen deficiency-induced bone loss in mice.
Kovacic N; Grcevic D; Katavic V; Lukic IK; Grubisic V; Mihovilovic K; Cvija H; Croucher PI; Marusic A
Lab Invest; 2010 Mar; 90(3):402-13. PubMed ID: 20084056
[TBL] [Abstract][Full Text] [Related]
14. Safranal inhibits estrogen-deficiency osteoporosis by targeting Sirt1 to interfere with NF-κB acetylation.
Sheng SR; Wu YH; Dai ZH; Jin C; He GL; Jin SQ; Zhao BY; Zhou X; Xie CL; Zheng G; Tian NF
Phytomedicine; 2023 Jun; 114():154739. PubMed ID: 37004404
[TBL] [Abstract][Full Text] [Related]
15. Effect of
Heo J; Kim M; Kim JH; Shin H; Lim SE; Jung HS; Sohn Y; Ku J
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297038
[TBL] [Abstract][Full Text] [Related]
16.
Hwang YH; Jang SA; Kim T; Ha H
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31398803
[TBL] [Abstract][Full Text] [Related]
17. Pan-histone deacetylase inhibitor vorinostat suppresses osteoclastic bone resorption through modulation of RANKL-evoked signaling and ameliorates ovariectomy-induced bone loss.
Peng X; Wang T; Wang Q; Zhao Y; Xu H; Yang H; Gu Y; Tao Y; Yan B; Xu Y; Geng D
Cell Commun Signal; 2024 Mar; 22(1):160. PubMed ID: 38439009
[TBL] [Abstract][Full Text] [Related]
18. Role of Mast-Cell-Derived RANKL in Ovariectomy-Induced Bone Loss in Mice.
Fischer V; Bülow JM; Krüger BT; Ragipoglu D; Vikman A; Haffner-Luntzer M; Katsoulis-Dimitriou K; Dudeck A; Ignatius A
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298085
[TBL] [Abstract][Full Text] [Related]
19. Cirsilineol inhibits RANKL-induced osteoclast activity and ovariectomy-induced bone loss via NF-κb/ERK/p38 signaling pathways.
Wang C; Zeng R; Li Y; He R
Chin Med; 2024 May; 19(1):69. PubMed ID: 38745234
[TBL] [Abstract][Full Text] [Related]
20. AS-605240 Blunts Osteoporosis by Inhibition of Bone Resorption.
Sun J; Cai G; Shen J; Cheng P; Zhang J; Jiang D; Xu X; Lu F; Chen L; Chen H
Drug Des Devel Ther; 2023; 17():1275-1288. PubMed ID: 37138583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
